The implementation of randomized trials in the treatment of advanced ovarian cancer with HIPEC: waiting for new evidence
Journal Title: Journal of Cancer Research & Therapy - Year 2013, Vol 1, Issue 1
Abstract
Ovarian cancer (OC) is one of the most frequent mortality causes among female neoplasms. A lot of data is available on the efficiency and the relative safety of the different treatments. In the last twenty years the overall survival (OS) and the disease free survival (DFS) have enormously incremented thanks to the combined chemotherapy regimens and the incredible progresses of surgery. These progresses are also related to the increased ability in managing patients more and more compromised, i.e. older and weaker. In addition to that, more than twenty years ago, Sugarbaker et al. started to treat the peritoneal cancer diffusion as a loco-regional disease. This change of practice has been demonstrated to be a real revolution by following studies.
Authors and Affiliations
Coccolini F, Lotti M, Catena F, Pisano M, Grosso G, Frigerio L, Ansaloni L
Keywords
Related Articles
- EP ID EP550159
- DOI 10.14312/2052-4994.2013-9
- Views 78
- Downloads 0
A clinical study on stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis
Purposes: Hepatocellular carcinoma with portal vein tumor thrombosis (HCC-PVTT) has a poor prognosis, while the optimal treatment remains controversial. The objective of this retrospective study was to evaluate the effic...
Burden, quality of life and distress of the main caregiver in head and neck, cervix and rectal cancer patients
Purpose: Based on Portuguese experience, current practice does not focus sufficiently on the caregiver needs through caring of the cancer patient. Understanding the impact of different tumor types on caregiver burden, qu...
Variability in the induction of alkaline phosphatase by histone deacetylase inhibitors in bladder and colon cancer cell lines
Induction of alkaline phosphatase activity has provided a convenient marker for differentiation of colon cancer cells. The degree to which different histone deacetylase inhibitors induce alkaline phosphatase and dipeptid...
Evaluation of serum big endothelin-1 for the diagnosis and prediction of disease recurrence in breast cancer patients
Big endothelin-1 (big ET-1) is the biological precursor of endothelin-1 (ET-1) and it is known as an indicator for the degree of activation of endothelin system. Therefore, this study was designed to investigate the seru...
Comparing docetaxel with gemcitabine as second-line chemotherapy in patients with advanced non-small cell lung cancer: A single institute randomized phase II study
Background: Platinum-based doublet chemotherapy is the backbone of treatment in advanced non-small cell lung cancer (NSCLC) however second-line treatment options are controversial particularly in patients with borderline...